Positions

Overview

  • Jasvinder Singh, MD, MPH, is Professor of Medicine and Epidemiology and holds the Musculoskeletal Outcomes Research Endowed Professor of Medicine. He has served as Director of the Rheumatology Research at the Birmingham VA Medical Center since 2009. He is also the Director of the UAB Cochrane Musculoskeletal Group Satellite Center since 2013; and the Director of the University of Alabama Health Services Foundation (UAHSF) Gout clinic since 2014. He currents serves on the FDA Arthritis Advisory Committee, and on the executive committee of Outcomes Measures in Rheumatology Trials (OMERACT). He is the current chair of the VA Rheumatology Field Advisory Committee (FAC) and the Chair of the Health Services Research Grant Review Committee of the Rheumatology Research Foundation (RRF).

    Dr. Singh’ research has been continuously funded by federal agencies (NIH, Department of Veterans Affairs, Patient Centered Outcomes Research Institute [PCORI]) and is focused largely on outcomes of arthritis and musculoskeletal diseases. He has authored more than 550 manuscripts, 20 book chapters and 34 editorials. He serves as investigator on multiple research grants focused on patient-reported outcomes, health disparities and comparative effectiveness research (CER) in gout, osteoarthritis, lupus, rheumatoid arthritis, and total joint replacement. Dr. Singh has collaborated with colleagues across several disciplines such as orthopedic surgery, physical medicine and rehabilitation, general internal medicine, oncology, exercise medicine, genetics and pain medicine.

    He was named recipient of the 2016 ACR Henry Kunkel Young Investigator Award, the 2017 Max Cooper Award for Research Excellence by the UAB Department of Medicine, and the 2018 Arthritis Foundation’s Lee C. Howley, Sr. award. He was named to the Best Doctors in America list yearly since 2011. Dr. Singh was previously a member of the American College of Rheumatology's (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care (QOC) Committees. In addition to membership on several ACR committees, he served as co-Chair of the ACR Criteria and Response Criteria subcommittee of the ACR QOC and the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee of the ACR AMPC.

    Dr. Singh’s academic medical training began by earning his M.B.B.S. from the University of Delhi, India in 1993. He then completed residency, at the Upstate Medical University at Syracuse, NY in 1998, followed by a fellowship in rheumatology at Washington Unviersity at St. Louis in 2001. Dr. Singh subsequently earned a M.P.H. from University of Minnesota in 2003.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Serious infections in Sjögren's syndrome patients: a national U.S. study.Clinical and Experimental Rheumatology2020
    2020 Which factors predict discordance between a patient and physician on a gout flare?Rheumatology2020
    2020 Hospitalized Infections in People with Osteoarthritis: A National U.S. Study.Journal of Rheumatology2020
    2020 How systemic sclerosis affects healthcare use and complication rates after total hip arthroplastyJournal of Rheumatology.  47:1218-1223. 2020
    2020 Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working groupSeminars in Arthritis and Rheumatism.  50:719-727. 2020
    2020 Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH) 2020
    2020 Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplastyClinical Rheumatology.  39:2345-2353. 2020
    2020 Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: A U.S. cohort studyBMC Musculoskeletal Disorders.  21. 2020
    2020 Assessment of a Satisfaction Measure for Use After Primary Total Joint ArthroplastyJournal of Arthroplasty.  35:1792-1799.e4. 2020
    2020 Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA) 2020
    2020 Serious infections in people with systemic sclerosis: A national US study 2020
    2020 Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: A study protocol for an OMERACT initiativeBMJ Open.  10. 2020
    2020 Identifying Physician-perceived Barriers to Apragmatictreatment Trial Inrheumatoid Arthritis 2020
    2020 Epidemiology, Time-trends and Outcomes of Serious Infections in Patients with Vasculitis: A 19-year National Study.Arthritis Care and Research2020
    2020 Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: Analysis for the Global Burden of Disease Study 2017 2020
    2020 2020 American College of Rheumatology Guideline for the Management of GoutArthritis Care and Research.  72:744-760. 2020
    2020 2020 American College of Rheumatology Guideline for the Management of GoutArthritis and Rheumatology.  72:879-895. 2020
    2020 A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout 2020
    2020 A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout. 2020
    2020 Gout epidemiology and comorbiditiesSeminars in Arthritis and Rheumatism.  50:S11-S16. 2020
    2020 Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey 2020
    2020 Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 2020
    2020 The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet Gastroenterology and Hepatology.  5:582-597. 2020
    2020 Allopurinol adherence and its predictors in gout: a national cohort study in US veteransLancet Rheumatology.  2:e281-e291. 2020
    2020 Flare rate thresholds for patient assessment of gout disease activity states.Journal of Rheumatology2020
    2020 Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017Nature Medicine.  26:750-759. 2020
    2020 Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical TrialsJournal of Arthroplasty.  35:1200-1207.e4. 2020
    2020 Serious Infections in People with Systemic sclerosis: A National U.S. Study 2020
    2020 Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathyCochrane Database of Systematic Reviews.  2020. 2020
    2020 Gout is associated with an increased risk for incident heart failure among older adults: The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study 2020
    2020 Serious Infections in People with Gout in the United States: A National Study of Incidence, Time-trends and Outcomes.Arthritis Care and Research2020
    2020 Hypersensitivity reactions with allopurinol and febuxostat: A study using the Medicare claims dataAnnals of the Rheumatic Diseases.  79:529-535. 2020
    2020 Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder ArthroplastyJournal of Rheumatology.  47:589-596. 2020
    2020 Examining Timeliness of Total Knee Replacement among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts 2020
    2020 Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplastyClinical Rheumatology.  39:881-890. 2020
    2020 Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in a US Veterans Affairs gout cohortJournal of Rheumatology.  47:449-460. 2020
    2020 Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomesClinical Rheumatology.  39:823-830. 2020
    2020 Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study 2020
    2020 The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet Gastroenterology and Hepatology.  5:245-266. 2020
    2020 The risk of Gougerot-Sjogren's syndrome in older adults with gout: A Medicare claims studyRevue du Rhumatisme.  87:110-115. 2020
    2020 Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 2020
    2020 Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study 2020
    2020 Acute kidney injury after primary total hip arthroplasty: A risk multiplier for complication, mortality, and healthcare utilization 2020
    2020 Medicaid Payer Status, Higher Comorbidity, and Low Income Are Associated With Poorer Outcomes After Total Elbow Arthroplasty. 2020
    2020 National U.S. Time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortalityPLoS ONE.  15. 2020
    2020 Serious Infections in People with Scleroderma: A National U.S. Study 2020
    2020 Patients' perspectives of outcomes after total knee and total hip arthroplasty: A nominal group studyBMC Rheumatology.  4. 2020
    2020 Mapping child growth failure across low- and middle-income countriesNature.  577:231-234. 2020
    2020 Mapping disparities in education across low- and middle-income countriesNature.  577:235-238. 2020
    2020 Acute kidney injury is associated with increased healthcare utilization, complications, and mortality after primary total knee arthroplastyTherapeutic Advances in Musculoskeletal Disease.  12. 2020
    2020 Allopurinol versus febuxostat hypersensitivity reactions in the US elderly: Differences in study outcomes and populations. Response to: 'Correspondence to "hypersensitivity reactions with allopurinol and febuxostat: A study using the Medicare claims data' by Ma et alAnnals of the Rheumatic Diseases2020
    2020 Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paperJournal of Clinical Epidemiology.  117:138-148. 2020
    2020 Gender and Ethnic Inequities in Gout Burden and ManagementRheumatic Disease Clinics of North America2020
    2020 Global injury morbidity and mortality from 1990 to 2017: Results from the Global Burden of Disease Study 2017Injury Prevention2020
    2020 Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: 'Confunding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: A study using the Medicare claims data'' by Hsu et alAnnals of the Rheumatic Diseases2020
    2020 Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacementScandinavian Journal of Rheumatology.  1-6. 2020
    2020 Misconceived expectations: Patient reflections on the total knee replacement journey 2020
    2020 Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis 2020
    2020 Response to: € Cutaneous adverse events with febuxostat after previous reactions to allopurinol: Comment on the artcile by Singh and Clevland' by Quills et alAnnals of the Rheumatic Diseases2020
    2020 Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US studyClinical Rheumatology2020
    2020 Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort StudyHypertension.  75:246-256. 2020
    2020 Systemic sclerosis is associated with knee arthroplasty outcomes: a National US studyClinical Rheumatology.  39:85-92. 2020
    2020 The Burden of Skin and Subcutaneous Diseases in the United States from 1990 to 2017JAMA Dermatology2020
    2020 The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet Gastroenterology and Hepatology.  5:17-30. 2020
    2020 The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017Lancet Gastroenterology and Hepatology.  5:42-54. 2020
    2019 Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.Journal of Rheumatology2019
    2019 Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease studyJAMA Oncology.  5:1749-1768. 2019
    2019 Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017Lancet HIV.  6:e831-e859. 2019
    2019 Total knee arthroplasty outcomes in lupus: A study using the US National Inpatient SampleRheumatology.  58:2130-2136. 2019
    2019 When has a knee or hip replacement failed? A patient perspective.Journal of Rheumatology2019
    2019 Polymyalgia Rheumatica Has Minimal Impact on Primary Total Knee or Hip Arthroplasty Outcomes. 2019
    2019 Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee ArthroplastyJAMA Network Open.  2:e1915105. 2019
    2019 Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of goutAnnals of the Rheumatic Diseases.  78:1592-1600. 2019
    2019 Mapping 123 million neonatal, infant and child deaths between 2000 and 2017Nature.  574:353-358. 2019
    2019 Association of Race/Ethnicity With Hospital Discharge Disposition After Elective Total Knee ArthroplastyJAMA Network Open.  2:e1914259. 2019
    2019 Are the days of missed or delayed diagnosis of gout over?Nature Reviews Rheumatology.  15:578-580. 2019
    2019 Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview studyClinical Rheumatology.  38:2793-2801. 2019
    2019 The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study 2019
    2019 Tai chi for rheumatoid arthritisCochrane Database of Systematic Reviews.  2019. 2019
    2019 Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: A propensity-matched analysis of Medicare claims dataEuropean Heart Journal.  40:3046-3054. 2019
    2019 Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence GroupJournal of Rheumatology.  46:1202-1206. 2019
    2019 Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS) (Clinical Rheumatology, (2019), 38, 4, (1213-1216), 10.1007/s10067-019-04434-3)Clinical Rheumatology.  38:2651-2653. 2019
    2019 Identifying provisional generic contextual factor domains for clinical trials in rheumatology: Results from an OMERACT initiativeJournal of Rheumatology.  46:1159-1163. 2019
    2019 Rates of total joint replacement in the United States: Future projections to 2020-2040 using the national inpatient sampleJournal of Rheumatology.  46:1134-1140. 2019
    2019 The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017 2019
    2019 Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticaseRheumatology.  58:1422-1431. 2019
    2019 Core domain Set selection according to OMERACT filter 2.1: The OMERACT methodologyJournal of Rheumatology.  46:1014-1020. 2019
    2019 Gout is associated with increased healthcare utilization after knee arthroplastyAnnals of the Rheumatic Diseases.  78:1146-1148. 2019
    2019 Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT premeeting toward consensus on core sets for randomized controlled trialsJournal of Rheumatology.  46:1053-1058. 2019
    2019 Instrument selection using the OMERACT filter 2.1: The OMERACT methodologyJournal of Rheumatology.  46:1028-1035. 2019
    2019 OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studiesJournal of Rheumatology.  46:1021-1027. 2019
    2019 The Third Biennial 2018 OMERACT First-time Participant Program: A qualitative and quantitative studyJournal of Rheumatology.  46:1036-1040. 2019
    2019 Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis 2019
    2019 GRADE guidelines: 22. The GRADE approach for tests and strategies—from test accuracy to patient-important outcomes and recommendationsJournal of Clinical Epidemiology.  111:69-82. 2019
    2019 Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?Drugs and Aging.  36:493-510. 2019
    2019 Lupus is associated with poorer outcomes after primary total hip arthroplastyLupus.  28:834-842. 2019
    2019 Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Neurology.  18:459-480. 2019
    2019 Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trialPLoS Medicine.  16. 2019
    2019 Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS)Clinical Rheumatology.  38:1213-1216. 2019
    2019 Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering TherapyDrugs.  79:531-541. 2019
    2019 Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Neurology.  18:376-393. 2019
    2019 Gout is associated with a higher risk of chronic renal disease in older adults: A retrospective cohort study of U.S. Medicare populationBMC Nephrology.  20. 2019
    2019 Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in GoutArthritis Care and Research.  71:427-434. 2019
    2019 Patient perspectives in gout: A reviewCurrent Opinion in Rheumatology.  31:159-166. 2019
    2019 The association of gout with incident giant cell arteritis in older adults 2019
    2019 A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator TrialsArthritis Care and Research.  71:319-322. 2019
    2019 Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital PerspectiveRheumatic Disease Clinics of North America.  45:39-51. 2019
    2019 General Assembly, Prevention, Host Related General: Proceedings of International Consensus on Orthopedic InfectionsJournal of Arthroplasty.  34:S13-S35. 2019
    2019 Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: Reality or dream?Annals of the Rheumatic Diseases.  78:153-154. 2019
    2019 Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: An Internet cross-sectional survey 2019
    2019 Gout and the risk of Parkinson's disease in older adults: A study of U.S. Medicare dataBMC Neurology.  19:V. 2019
    2019 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic ArthritisJournal of Psoriasis and Psoriatic Arthritis.  4:31-58. 2019
    2019 Burden of injury along the development spectrum: Associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017Injury Prevention2019
    2019 Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016BMJ.  364. 2019
    2019 Gout and chronic pain in older adults: a Medicare claims studyClinical Rheumatology2019
    2019 Gout and sexual function: Patient perspective of how gout affects personal relationships and intimacyBMC Rheumatology.  3. 2019
    2019 Is there a role for cherries in the management of gout?Therapeutic Advances in Musculoskeletal Disease.  11:1759720X19847018. 2019
    2019 OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making InterventionsJournal of Rheumatology.  46:1409-1414. 2019
    2019 Pain measurement in rheumatic and musculoskeletal diseases: Where to go from here? Report from a special interest group at OMERACT 2018Journal of Rheumatology.  46:355-1359. 2019
    2019 Race, Discharge Disposition, and Readmissions after Elective Hip Replacement: Analysis of a Large Regional DatasetHealth Equity.  3:628-636. 2019
    2019 Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic ArthritisArthritis Care and Research.  71:2-29. 2019
    2019 Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic ArthritisArthritis and Rheumatology.  71:5-32. 2019
    2018 Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysisTherapeutic Advances in Musculoskeletal Disease.  10:235-252. 2018
    2018 Global, regional, and national burden of tuberculosis, 1990-2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 StudyLancet Infectious Diseases.  18:1329-1349. 2018
    2018 Gout and the risk of incident depression in older adultsPsychiatry Research.  270:842-844. 2018
    2018 Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)) 2018
    2018 Gout and dementia in the elderly: A cohort study of Medicare claimsBMC Geriatrics.  18. 2018
    2018 Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines (Clinical Rheumatology, (2018), 37, 11, (2947-2959), 10.1007/s10067-018-4245-5)Clinical Rheumatology.  37:2961-2962. 2018
    2018 Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Infectious Diseases.  18:1191-1210. 2018
    2018 Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?Arthritis Care and Research.  70:1694-1699. 2018
    2018 Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 2018
    2018 Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelinesClinical Rheumatology.  37:2947-2959. 2018
    2018 Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patientsOsteoarthritis and Cartilage.  26:1311-1318. 2018
    2018 Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and SongAnnals of the Rheumatic Diseases.  77:e74. 2018
    2018 Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysisSeminars in Arthritis and Rheumatism.  48:293-301. 2018
    2018 Gout and the risk of incident obstructive sleep apnea in adults 65 years or older: An observational study 2018
    2018 Goals of gout treatment: a patient perspectiveClinical Rheumatology.  37:2557-2566. 2018
    2018 Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplastyClinical Rheumatology.  37:2489-2496. 2018
    2018 Global mortality from firearms, 1990-2016 2018
    2018 Opioids vs nonopioids for chronic back, hip, or knee pain 2018
    2018 Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: A propensity-matched analysis 2018
    2018 Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims DataJournal of General Internal Medicine.  33:1229-1231. 2018
    2018 Gout and hearing impairment in the elderly: A retrospective cohort study using the US Medicare claims dataBMJ Open.  8. 2018
    2018 Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adultsAnnals of the Rheumatic Diseases.  77:1243-1245. 2018
    2018 Expert opinion on emerging urate-lowering therapiesExpert Opinion on Emerging Drugs.  23:201-209. 2018
    2018 Association of gout with uveitis in older individualsJAMA Ophthalmology.  136:835-837. 2018
    2018 Gout and the risk of age-related macular degeneration in the elderlyPLoS ONE.  13. 2018
    2018 Response to: 'A response to singh. “Lesinurad combination therapy with allopurinol in gout: Do CLEAR studies make the treatment of gout clearer?”' by valiyil and schechterAnnals of the Rheumatic Diseases.  77. 2018
    2018 The risk of polymyalgia rheumatica in older adults with gout: A Medicare claims studyRheumatology Advances in Practice.  2:1-7. 2018
    2018 Interleukin inhibitors for psoriatic arthritisCochrane Database of Systematic Reviews.  2018. 2018
    2018 Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016 2018
    2018 Gout and the risk of myocardial infarction in older adults: A study of Medicare recipients 2018
    2018 Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities 2018
    2018 Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study 2018
    2018 Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study 2018
    2018 Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study 2018
    2018 Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study 2018
    2018 Development of the American College of Rheumatology Electronic Clinical Quality Measures for GoutArthritis Care and Research.  70:659-671. 2018
    2018 Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study 2018
    2018 Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)British Journal of Dermatology.  178:e332-e341. 2018
    2018 The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: findings from the global burden of disease 2015 study 2018
    2018 Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study 2018
    2018 The state of US health, 1990-2016: Burden of diseases, injuries, and risk factors among US states 2018
    2018 Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: The VAPAIN consensus statement on core outcome domainsPAIN.  159:673-683. 2018
    2018 EULAR gout treatment guidelines by Richette et al.: Uric acid and neurocognitionAnnals of the Rheumatic Diseases.  77. 2018
    2018 Epilepsy and psychosis: A practical approachPractical Neurology.  18:106-114. 2018
    2018 Medication adherence among patients with gout: A systematic review and meta-analysisSeminars in Arthritis and Rheumatism.  47:689-702. 2018
    2018 Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study ProtocolTrials.  19. 2018
    2018 Allopurinol and the risk of incident peripheral arterial disease in the elderly: A us medicare claims data studyRheumatology.  57:451-461. 2018
    2018 Brief Report: Validation of a Definition of Flare in Patients With Established GoutArthritis and Rheumatology.  70:462-467. 2018
    2018 Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinkingAnnals of the Rheumatic Diseases.  77:317-318. 2018
    2018 The global burden of tuberculosis: results from the Global Burden of Disease Study 2015Lancet Infectious Diseases.  18:261-284. 2018
    2018 Trends in opioid and nonsteroidal anti-inflammatory use and adverse eventsAmerican Journal of Managed Care.  24:e61-e72. 2018
    2018 Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirementsJournal of Rheumatology.  45:419-424. 2018
    2018 Correction: Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials. [Arthritis Res Ther. 19, (2017)(267)] DOI: 10.1186/s13075-017-1476-9 2018
    2018 Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time TrendsArthritis Care and Research.  70:320-326. 2018
    2018 Taking an Interdisciplinary Approach to Understanding and Improving Medication AdherenceJournal of General Internal Medicine.  33:136-138. 2018
    2018 Trends in joint replacement surgery in patients with rheumatoid arthritisJournal of Rheumatology.  45:158-164. 2018
    2018 Any sleep is a dream far away: A nominal group study assessing how gout affects sleepRheumatology.  57:1925-1932. 2018
    2018 Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance).International Journal of Statistics in Medical Research.  7:137-146. 2018
    2018 Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data.RMD Open.  4:e000712. 2018
    2017 Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials 2017
    2017 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major SubgroupsArthritis and Rheumatology.  69:2271-2282. 2017
    2017 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroupsAnnals of the Rheumatic Diseases.  76:1955-1964. 2017
    2017 Considering health equity when moving from evidence-based guideline recommendations to implementation: A case study from an upper-middle income country on the GRADE approachHealth Policy and Planning.  32:1484-1490. 2017
    2017 Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016Journal of Rheumatology.  44:1889-1893. 2017
    2017 Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathyCochrane Database of Systematic Reviews.  2017. 2017
    2017 Weight loss for overweight patients with knee or hip osteoarthritisCochrane Database of Systematic Reviews.  2017. 2017
    2017 Achieving consensus on total joint replacement trial outcome reporting using the OMERACT filter: Endorsement of the final core domain set for total hip and total knee replacement trials for endstage arthritisJournal of Rheumatology.  44:1723-1726. 2017
    2017 Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' PerspectivesArthritis Care and Research.  69:1724-1732. 2017
    2017 Health equity considerations for developing and reporting patient-reported outcomes in clinical trials: A report from the omeract equity special interest groupJournal of Rheumatology.  44:1727-1733. 2017
    2017 Patient-Reported Outcomes Can Be Used to Streamline Post-Total Hip Arthroplasty Follow-Up to High-Risk PatientsJournal of Arthroplasty.  32:3319-3321. 2017
    2017 Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studiesAnnals of the Rheumatic Diseases.  76:1870-1882. 2017
    2017 Erratum: Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (The Lancet (2017) 390(10100) (1423–1459) (S014067361732336X) (10.1016/S0140-6736(17)32336-X)) 2017
    2017 Erratum: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE Adolopment [Health Qual Life Outcomes., 15, (2017)(183)] DOI: 10.1186/s12955-017-0754-1Health and Quality of Life Outcomes.  15. 2017
    2017 Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study 2017
    2017 Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: An analysis of Medicare claims dataAnnals of the Rheumatic Diseases.  76:1669-1678. 2017
    2017 Engaging stakeholders and promoting uptake of OMERACT core outcome instrument setsJournal of Rheumatology.  44:1551-1559. 2017
    2017 GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationaleJournal of Clinical Epidemiology.  90:59-67. 2017
    2017 GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklistJournal of Clinical Epidemiology.  90:68-75. 2017
    2017 GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceJournal of Clinical Epidemiology.  90:76-83. 2017
    2017 GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision processJournal of Clinical Epidemiology.  90:84-91. 2017
    2017 Patient Burden of Axial Spondyloarthritis 2017
    2017 Patient Burden of Axial Spondyloarthritis. 2017
    2017 The OMERACT first-time participant program: Fresh eye from the new guysJournal of Rheumatology.  44:1560-1563. 2017
    2017 Erratum:Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (The Lancet (2017) 390(10100) (1423–1459) (S014067361732336X)(10.1016/S0140-6736(17)32336-X)) 2017
    2017 Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE AdolopmentHealth and Quality of Life Outcomes.  15. 2017
    2017 Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016 2017
    2017 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 2017
    2017 Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 2017
    2017 Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 2017
    2017 Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016 2017
    2017 Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016 2017
    2017 Gout and comorbidity: A nominal group study of people with gout 2017
    2017 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastyJournal of Arthroplasty.  32:2628-2638. 2017
    2017 Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US VeteransArthritis Care and Research.  69:1400-1406. 2017
    2017 Biologic drugs for induction and maintenance of remission in Crohn's disease: A network meta-analysisCochrane Database of Systematic Reviews.  2017. 2017
    2017 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastyArthritis and Rheumatology.  69:1538-1551. 2017
    2017 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastyArthritis Care and Research.  69:1111-1124. 2017
    2017 Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013Annals of the Rheumatic Diseases.  76:1365-1373. 2017
    2017 Clinical Practice Guidelines: Incorporating Input From a Patient PanelArthritis Care and Research.  69:1125-1130. 2017
    2017 Outcome measures used in arthroplasty trials: Systematic review of the 2008 and 2013 literatureJournal of Rheumatology.  44:1277-1287. 2017
    2017 The burden of septic arthritis on the U.S. inpatient care: A national studyPLoS ONE.  12. 2017
    2017 Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015 2017
    2017 Health effects of overweight and obesity in 195 countries over 25 yearsNew England Journal of Medicine.  377:13-27. 2017
    2017 Management of goutAnnals of Internal Medicine.  166:855. 2017
    2017 Child and adolescent health from 1990 to 2015: Findings from the global burden of diseases, injuries, and risk factors 2015 studyJAMA Pediatrics.  171:573-592. 2017
    2017 Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trialsSeminars in Arthritis and Rheumatism.  46:699-708. 2017
    2017 Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trialClinical Rheumatology.  36:1357-1367. 2017
    2017 Receipt of Pain Management Information Preoperatively Is Associated With Improved Functional Gain After Elective Total Joint ArthroplastyJournal of Arthroplasty.  32:1763-1768. 2017
    2017 Health care utilization in patients with gout: a prospective multicenter cohort studyBMC Musculoskeletal Disorders.  18. 2017
    2017 Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literatureSystematic Reviews.  6. 2017
    2017 Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the global burden of disease study 2015 2017
    2017 Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: A systematic review and network meta-analysisCochrane Database of Systematic Reviews.  2017. 2017
    2017 Lesinurad combination therapy with allopurinol in gout: Do CLEAR studies make the treatment of gout clearer?Annals of the Rheumatic Diseases.  76:779-781. 2017
    2017 Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infectionJournal of Rheumatology.  44:565-570. 2017
    2017 Chasing crystals out of the body: Will treat to serum urate target for gout help us get there?Annals of the Rheumatic Diseases.  76:629-631. 2017
    2017 Evaluation and Management of the Patient With Suspected Inflammatory Spine DiseaseMayo Clinic Proceedings.  92:555-564. 2017
    2017 Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statementBritish Journal of Dermatology.  176:979-984. 2017
    2017 Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT) 2017
    2017 Allopurinol and the risk of ventricular arrhythmias in the elderly: A study using US Medicare dataBMC Medicine.  15. 2017
    2017 Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain setBMC Musculoskeletal Disorders.  18. 2017
    2017 Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetesBMC Cardiovascular Disorders.  17. 2017
    2017 Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: A systematic review and network meta-analysisCochrane Database of Systematic Reviews.  2017. 2017
    2017 Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trialBMC Musculoskeletal Disorders.  18:1-10. 2017
    2017 Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: A report from the International consensus on outcome measures in TJR trials (I-COMiTT) groupBMC Musculoskeletal Disorders.  18. 2017
    2017 Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: A pilot studyBMC Musculoskeletal Disorders.  18. 2017
    2017 An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplastyBMC Musculoskeletal Disorders.  18. 2017
    2017 Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) 2017
    2017 Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)) 2017
    2017 Allopurinol and the risk of atrial fibrillation in the elderly: A study using medicare dataAnnals of the Rheumatic Diseases.  76:72-78. 2017
    2017 Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failureAnnals of the Rheumatic Diseases.  76:133-139. 2017
    2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: A methodology reportRMD Open.  3. 2017
    2017 Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Obstetrical and Gynecological Survey.  72:11-13. 2017
    2017 Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients. 2017
    2017 Racial differences in health-related quality of life and functional ability in patients with goutRheumatology.  56:103-112. 2017
    2017 Renal dosing of allopurinol results in suboptimal gout careAnnals of the Rheumatic Diseases.  76. 2017
    2017 The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis StudyArthritis and Rheumatology.  69:94-102. 2017
    2017 The Burden of the Fellowship Interview Process on General Surgery Residents and Programs 2017
    2016 Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient ContextArthritis Care and Research.  68:1787-1794. 2016
    2016 Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: A Cochrane Systematic Review and network meta-analysis (NMA)Cochrane Database of Systematic Reviews.  2016. 2016
    2016 Gout: Will the "King of Diseases" Be the first rheumatic disease to be curedBMC Medicine.  14. 2016
    2016 Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality MeasuresArthritis Care and Research.  68:1579-1590. 2016
    2016 Nonunion of first rib fracture in a softball player: case report of a rare cause of thoracic outlet syndromeJournal of Shoulder and Elbow Surgery.  25:e353-e357. 2016
    2016 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 2016
    2016 Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 2016
    2016 Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplastyBMC Musculoskeletal Disorders.  17:1-10. 2016
    2016 Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritisAnnals of the Rheumatic Diseases.  75:1813-1818. 2016
    2016 Does T'ai Chi Gait Reduce External Knee Adduction Moment?Journal of Alternative and Complementary Medicine.  22:818-823. 2016
    2016 Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational StudiesCurrent Rheumatology Reports.  18. 2016
    2016 Sex-related Outcome Inequalities in Endovascular Aneurysm RepairEuropean Journal of Vascular and Endovascular Surgery.  52:518-525. 2016
    2016 Treatments for lupus nephritis: A systematic review and network metaanalysisJournal of Rheumatology.  43:1801-1815. 2016
    2016 Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: A study of Medicare claims 2016
    2016 Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysisBMJ Open.  6:e012026. 2016
    2016 Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: A systematic review and network meta-analysisSystematic Reviews.  5. 2016
    2016 Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: A systematic review and network meta-analysisBMC Medicine.  14. 2016
    2016 Allopurinol and the risk of stroke in older adults receiving medicareBMC Neurology.  16. 2016
    2016 Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendationsPAIN.  157:1836-1850. 2016
    2016 Erratum: Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: The Global Burden of Disease Study 2015 (The Lancet HIV (2016) 3 (e361-e387) PII: S235230181630087X DOI: 10.1016/S2352-3018(16)30087-X)Lancet HIV.  3:e408. 2016
    2016 Metabolic syndrome and shoulder arthroplasty: epidemiology and peri-operative outcomesInternational Orthopaedics.  40:1927-1933. 2016
    2016 Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for VaccinationArthritis and Rheumatology.  68:2328-2337. 2016
    2016 How often is the office visit needed? Predicting total knee arthroplasty revision risk using pain/function scoresBMC Health Services Research.  16. 2016
    2016 Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015Lancet HIV.  3:e361-e387. 2016
    2016 GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public healthJournal of Clinical Epidemiology.  76:89-98. 2016
    2016 Time trends, predictors, and outcome of emergency department use for gout: A nationwide US studyJournal of Rheumatology.  43:1581-1588. 2016
    2016 Emergency Department and Inpatient Healthcare utilization due to HypertensionBMC Health Services Research.  16. 2016
    2016 Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogelsInternational Journal of Pharmaceutics.  509:465-476. 2016
    2016 Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: To worry or not to worry?Annals of the Rheumatic Diseases.  75:1265-1267. 2016
    2016 Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)British Journal of Dermatology.  175:69-79. 2016
    2016 Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplastyBMC Musculoskeletal Disorders.  17. 2016
    2016 Performance of Gout Impact Scale in a longitudinal observational study of patients with goutRheumatology.  55:982-990. 2016
    2016 Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: A systematic review and network meta-analysisCochrane Database of Systematic Reviews.  2016. 2016
    2016 Do pessimists report worse outcomes after total hip arthroplasty?BMC Musculoskeletal Disorders.  17. 2016
    2016 Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus ExercisesArthritis Care and Research.  68:667-672. 2016
    2016 ReplyArthritis and Rheumatology.  68:1316-1318. 2016
    2016 ReplyArthritis Care and Research.  68:725-726. 2016
    2016 Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adultsCochrane Database of Systematic Reviews.  2016. 2016
    2016 Ms. A.M. Taylor, et al replyJournal of Rheumatology.  43:826. 2016
    2016 Racial/Ethnic Disparity in Rates and Outcomes of Total Joint ArthroplastyCurrent Rheumatology Reports.  18. 2016
    2016 The Global Burden of Anemia 2016
    2016 Gout-related inpatient utilization: A study of predictors of outcomes and time trends 2016
    2016 A cross-sectional internet-based patient survey of the management strategies for goutBMC Complementary and Alternative Medicine.  16. 2016
    2016 Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sampleClinical Rheumatology.  35:723-731. 2016
    2016 Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: Data from the National Veterans Health AdministrationAnnals of the Rheumatic Diseases.  75:341-347. 2016
    2016 Does rural residence impact total ankle arthroplasty utilization and outcomes?Clinical Rheumatology.  35:381-386. 2016
    2016 Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index 2016
    2016 Validation of the Mayo Hip Score: Construct validity, reliability and responsiveness to change Orthopedics and biomechanicsBMC Musculoskeletal Disorders.  17. 2016
    2016 Utilization due to chronic obstructive pulmonary disease and its predictors: A study using the U.S. National Emergency Department Sample (NEDS)Respiratory Research.  17. 2016
    2016 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis and Rheumatology.  68:1-26. 2016
    2016 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis and Rheumatology.  68:1-26. 2016
    2016 Depression and anxiety following coronary artery bypass graft: Current indian scenarioCardiology Research and Practice.  2016. 2016
    2016 GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelinesBMJ.  353. 2016
    2016 Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient SampleClinical Rheumatology.  35:239-245. 2016
    2016 When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid ArthritisArthritis Care and Research.  68:26-35. 2016
    2015 Minorities with lupus nephritis and medications: A study of facilitators to medication decision-making 2015
    2015 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2015
    2015 Imaging as an outcome measure in gout studies: Report from the OMERACT gout working groupJournal of Rheumatology.  42:2460-2464. 2015
    2015 Outcome domains and measures in total joint replacement clinical trials: Can we harmonize them? An OMERACT collaborative initiativeJournal of Rheumatology.  42:2496-2502. 2015
    2015 Toward ensuring health equity: Readability and cultural equivalence of OMERACT patient-reported outcome measuresJournal of Rheumatology.  42:2448-2459. 2015
    2015 Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition 2015
    2015 Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: A prospective cohort studyBMC Medicine.  13. 2015
    2015 Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?Clinical Orthopaedics and Related Research.  473:3446-3455. 2015
    2015 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative InitiativeArthritis and Rheumatology.  67:2557-2568. 2015
    2015 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases.  74:1789-1798. 2015
    2015 Age-related differences in the use of total shoulder arthroplasty over time: USE and OUTCOMESBone and Joint Journal.  97-B:1385-1389. 2015
    2015 Consensus on the need for a hierarchical list of patient-reported pain outcomes for metaanalyses of knee osteoarthritis trials: An OMERACT objectiveJournal of Rheumatology.  42:1971-1975. 2015
    2015 Current state of reporting pain outcomes in cochrane reviews of chronic musculoskeletal pain conditions and considerations for an OMERACT research agendaJournal of Rheumatology.  42:1934-1942. 2015
    2015 Harmonizing pain outcome measures: Results of the pre-OMERACT meeting on partnerships for consensus on patient-important pain outcome domains between the cochrane musculoskeletal group and OMERACTJournal of Rheumatology.  42:1943-1946. 2015
    2015 Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic painJournal of Rheumatology.  42:1947-1953. 2015
    2015 Are there racial disparities in utilization and outcomes after total elbow arthroplasty? 2015
    2015 Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: Analyses from large U.S. managed care cohort [Arthritis Res Ther. 2015;17:120] 2015
    2015 Validity and sensitivity to change of three scales for the radiographic assessment of knee osteoarthritis using images from the Multicenter Osteoarthritis Study (MOST)Osteoarthritis and Cartilage.  23:1491-1498. 2015
    2015 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2015
    2015 Persisting racial disparities in total shoulder arthroplasty utilization and outcomesJournal of Racial and Ethnic Health Disparities.  3:259-266. 2015
    2015 Adherence to the 2012 American college of rheumatology (ACR) guidelines for management of gout: A survey of Brazilian rheumatologistsPLoS ONE.  10. 2015
    2015 Investigational drugs for hyperuricemiaExpert Opinion on Investigational Drugs.  24:1013-1030. 2015
    2015 Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)Osteoporosis International.  26:1971-1977. 2015
    2015 The Global Burden of Cancer 2013JAMA Oncology.  1:505-527. 2015
    2015 Total joint replacement surgery for knee osteoarthritis and other non-traumatic diseases: A network meta-analysisCochrane Database of Systematic Reviews.  2015. 2015
    2015 Subcutaneous or intramuscular methotrexate for rheumatoid arthritisCochrane Database of Systematic Reviews.  2015. 2015
    2015 Validation of administrative codes for calcium pyrophosphate deposition: A veterans administration study 2015
    2015 Outcomes of augmented allograft figure-of-eight sternoclavicular joint reconstructionJournal of Shoulder and Elbow Surgery.  24:902-907. 2015
    2015 The Effect of Arthroscopic Rotator Interval Closure on Glenohumeral Volume 2015
    2015 Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: A retrospective cohort study 2015
    2015 Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: Analyses from large U.S. managed care cohort 2015
    2015 TNF-alpha inhibitors for ankylosing spondylitisCochrane Database of Systematic Reviews.  2015. 2015
    2015 When gout goes to the heart: Does gout equal a cardiovascular disease risk factor?Annals of the Rheumatic Diseases.  74:631-634. 2015
    2015 Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adultsCochrane Database of Systematic Reviews.  2015. 2015
    2015 Racial disparities in total ankle arthroplasty utilization and outcomes 2015
    2015 Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adultsCochrane Database of Systematic Reviews.  2015. 2015
    2015 Exercise therapy following surgical rotator cuff repairCochrane Database of Systematic Reviews.  2015. 2015
    2015 Chondroitin for osteoarthritisCochrane Database of Systematic Reviews.  2017. 2015
    2015 Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2015
    2015 A call for evidence-based decision making when selecting outcome measurement instruments for summary of findings tables in systematic reviews: Results from an OMERACT working groupJournal of Rheumatology.  42:1954-1961. 2015
    2015 A real-world study of switching from allopurinol to febuxostat in a health plan database 2015
    2015 An Internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements 2015
    2015 Assessing the reading level of online sarcoma patient education materials 2015
    2015 Barriers to medication decision making in women with lupus nephritis: A formative study using nominal group techniqueJournal of Rheumatology.  42:1616-1623. 2015
    2015 Comparative analysis of anatomic and reverse total shoulder arthroplasty: In-hospital outcomes and costsJournal of Shoulder and Elbow Surgery.  24:460-467. 2015
    2015 Do "evidence-based recommendations" need to reveal the evidence? Minimal criteria supporting an "evidence claim"Journal of Rheumatology.  42:1737-1739. 2015
    2015 Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US?Arthritis Care and Research.  67:885-890. 2015
    2015 Is the double contour sign specific for gout? Or only for crystal arthritis?Journal of Rheumatology.  42:353-354. 2015
    2015 Muscle inflammation susceptibility: A prognostic index of recovery potential after hip arthroplasty? 2015
    2015 Optimal strategies for reporting pain in clinical trials and systematic reviews: Recommendations from an OMERACT 12 workshopJournal of Rheumatology.  42:1962-1970. 2015
    2015 Patient-centered priorities for improving medication management and adherencePatient Education and Counseling.  98:102-110. 2015
    2015 Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes.Journal of Racial and Ethnic Health Disparities.  2015:1-8. 2015
    2015 Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort studyArthritis Care and Research.  67:718-724. 2015
    2015 Risk of serious infection in biological treatment of patients with rheumatoid arthritis: A systematic review and meta-analysis 2015
    2015 The OMERACT first-time participant ("Newbie") program: Initial assessment and lessons learnedJournal of Rheumatology.  42:1976-1981. 2015
    2014 Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scalesHealth and Quality of Life Outcomes.  12. 2014
    2014 Antidepressants for people with epilepsy and depressionCochrane Database of Systematic Reviews.  2014. 2014
    2014 Racial disparities in knee and hip total joint arthroplasty: An 18-year analysis of national medicare dataAnnals of the Rheumatic Diseases.  73:2107-2115. 2014
    2014 Impaired response or insufficient dosage?-Examining the potential causes of "inadequate response" to allopurinol in the treatment of goutSeminars in Arthritis and Rheumatism.  44:170-174. 2014
    2014 A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysisBMJ.  349. 2014
    2014 Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2014
    2014 The impact of gout on patient's lives: A study of African-American and Caucasian men and women with gout 2014
    2014 Antipsychotics for people with epilepsy and psychosisCochrane Database of Systematic Reviews.  2014. 2014
    2014 Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee functionBMC Musculoskeletal Disorders.  15. 2014
    2014 Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: A qualitative study 2014
    2014 Patient-level improvements in pain and activities of daily living after total knee arthroplastyRheumatology.  53:313-320. 2014
    2014 Underlying diagnosis predicts patient-reported outcomes after revision total knee arthroplastyRheumatology.  53:361-366. 2014
    2014 Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiencesJournal of Rheumatology.  41:206-215. 2014
    2014 Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalysesJournal of Rheumatology.  41:194-205. 2014
    2014 Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute goutJournal of Rheumatology.  41:574-580. 2014
    2014 Are outcomes after total knee arthroplasty worsening over time? A time-trends study of activity limitation and pain outcomesBMC Musculoskeletal Disorders.  15. 2014
    2014 Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well?Arthritis and Rheumatology.  66:250-253. 2014
    2014 Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomesJournal of Arthroplasty.  29:1359-1364. 2014
    2014 Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: An updateQuality of Life Research.  23:1997-2013. 2014
    2014 Cerebrovascular disease is associated with outcomes after total knee arthroplasty: A us total joint registry studyJournal of Arthroplasty.  29:40-43. 2014
    2014 Challenges faced by patients in gout treatment: A qualitative study 2014
    2014 Comorbidities in patients with crystal diseases and hyperuricemiaRheumatic Disease Clinics of North America.  40:251-278. 2014
    2014 Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0Journal of Clinical Epidemiology.  67:745-753. 2014
    2014 Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplastyJournal of Shoulder and Elbow Surgery.  23:671-678. 2014
    2014 Does clinically important change in function after knee replacement guarantee good absolute function? the multicenter osteoarthritis studyJournal of Rheumatology.  41:60-64. 2014
    2014 Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study.British Journal of Medicine and Medical Research.  4. 2014
    2014 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2014
    2014 Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 2014
    2014 Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 2014
    2014 How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Journal of Rheumatology.  41:1025-1030. 2014
    2014 Improving the readability of online foot and ankle patient education materialsFoot and Ankle International.  35:1282-1286. 2014
    2014 Including health equity considerations in development of instruments for rheumatology research: An introduction to a novel OMERACT paradigmJournal of Rheumatology.  41:150-152. 2014
    2014 Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: A 13-year study of time trendsBMC Musculoskeletal Disorders.  15. 2014
    2014 Introduction: OMERACT 11 - International consensus conference on outcome measures in rheumatology clinical trialsJournal of Rheumatology.  41:145-149. 2014
    2014 Methotrexate use and liver disease - A causal relationship?British Journal of Dermatology.  171:6-7. 2014
    2014 OMERACT endorsement of measures of outcome for studies of acute goutJournal of Rheumatology.  41:569-573. 2014
    2014 Outcome measures in acute gout: A systematic literature reviewJournal of Rheumatology.  41:558-568. 2014
    2014 Patient-centered interventions to improve medication management and adherence: A qualitative review of research findingsPatient Education and Counseling.  97:310-326. 2014
    2014 Predictors of pain medication use for arthroplasty pain after revision total knee arthroplastyRheumatology.  53:1752-1758. 2014
    2014 Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: A multicenter studyJournal of Rheumatology.  41:509-515. 2014
    2014 Remembering the forgotten non-communicable diseasesBMC Medicine.  12. 2014
    2014 Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)British Journal of Dermatology.  171:1318-1325. 2014
    2014 Research priorities in gout: The patient perspectiveJournal of Rheumatology.  41:615-616. 2014
    2014 Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritisArthritis Care and Research.  66:990-997. 2014
    2014 The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trialsJournal of Allergy and Clinical Immunology.  134:800-807. 2014
    2014 Time trends in the characteristics of patients undergoing primary total knee arthroplastyArthritis Care and Research.  66:897-906. 2014
    2014 Trends in and disparities for acute myocardial infarction: An analysis of Medicare claims data from 1992 to 2010BMC Medicine.  12. 2014
    2014 Updating the OMERACT Filter: Core areas as a basis for defining core outcome setsJournal of Rheumatology.  41:994-999. 2014
    2014 Updating the OMERACT filter: Implications for imaging and soluble biomarkersJournal of Rheumatology.  41:1016-1024. 2014
    2014 Updating the omeract filter: Discrimination and feasibilityJournal of Rheumatology.  41:1005-1010. 2014
    2014 Updating the omeract filter: Implications of filter 2.0 to select outcome instruments through assessment of "truth": Content, face, and construct validityJournal of Rheumatology.  41:1000-1004. 2014
    2013 Veterans Affairs databases are accurate for gout-related health care utilization: A validation study 2013
    2013 Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: A cohort studyArthritis Care and Research.  65:1936-1941. 2013
    2013 Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better.Cochrane Database of Systematic Reviews.  7. 2013
    2013 Ofatumumab for rheumatoid arthritisCochrane Database of Systematic Reviews.  2013. 2013
    2013 Diabetes: A risk factor for poor functional outcome after total knee arthroplastyPLoS ONE.  8. 2013
    2013 Participation following knee replacement: The MOST cohort studyPhysical Therapy.  93:1467-1474. 2013
    2013 Antipsychotics for people with epilepsy and psychosisCochrane Database of Systematic Reviews.  2013. 2013
    2013 Impact of health education on knowledge and practices about menstruation among adolescent school girls of rural part of district Ambala, HaryanaIndian Journal of Community Health.  25:492-497. 2013
    2013 Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: A cohort studyBMC Medicine.  11. 2013
    2013 Total joint replacement surgery versus conservative care for knee osteoarthritis and other non-traumatic diseasesCochrane Database of Systematic Reviews.  2013. 2013
    2013 Total hip replacement surgery versus conservative care for hip osteoarthritis and other non-traumatic diseasesCochrane Database of Systematic Reviews.  2013. 2013
    2013 Yield and quality of malt barley (Hordeum vulgare) as influenced by irrigation, nitrogen and methods of sowingIndian Journal of Agronomy.  58:354-362. 2013
    2013 Antidepressants for people with epilepsy and depressionCochrane Database of Systematic Reviews.  2013. 2013
    2013 Perioperative interventions for smoking cessation in hip and knee arthroplasty for osteoarthritis and other non-traumatic diseasesCochrane Database of Systematic Reviews.  2013. 2013
    2013 Belimumab for systemic lupus erythematosusCochrane Database of Systematic Reviews.  2013. 2013
    2013 Use of botulinum toxin in musculoskeletal painF1000Research.  2. 2013
    2013 Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs)BMC Musculoskeletal Disorders.  14. 2013
    2013 Sex and surgical outcomes and mortality after primary total knee arthroplasty: A risk-adjusted analysisArthritis Care and Research.  65:1095-1102. 2013
    2013 Productivity and quality of malt barley (Hordeum vulgare) as affected by sowing date, rate and stage of nitrogen applicationIndian Journal of Agronomy.  58:72-80. 2013
    2013 The relation between cancer patient treatment decision-making roles and quality of lifeCancer.  119:2342-2349. 2013
    2013 Use of biologics in a patient with rheumatoid arthritis refractory to methotrexateCMAJ.  185:793-795. 2013
    2013 Memantine for schizophreniaCochrane Database of Systematic Reviews.  2013. 2013
    2013 Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplastyBMC Medicine.  11. 2013
    2013 The influence of the contralateral knee prior to knee arthroplasty on post-arthroplasty function: The Multicenter Osteoarthritis Study 2013
    2013 Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: Data from a large US institutional registryRheumatology.  52:1109-1118. 2013
    2013 Mediation of smoking-associated postoperative mortality by perioperative complications in veterans undergoing elective surgery: Data from Veterans Affairs Surgical Quality Improvement Program (VASQIP)a cohort studyBMJ Open.  3. 2013
    2013 Clinically important body weight gain following knee arthroplasty: A five-year comparative cohort studyArthritis Care and Research.  65:669-677. 2013
    2013 Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplastyRheumatology.  52:916-923. 2013
    2013 ReplyArthritis Care and Research.  65:832-833. 2013
    2013 Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics?Nature Reviews Rheumatology.  9:200-202. 2013
    2013 Gout-related health care utilization in US emergency departments, 2006 through 2008Arthritis Care and Research.  65:571-577. 2013
    2013 Predictors of periprosthetic fracture after total knee replacement: An analysis of 21,723 casesActa Orthopaedica.  84:170-177. 2013
    2013 Harms of TNF inhibitors in rheumatic diseases: A focused review of the literatureImmunotherapy.  5:265-299. 2013
    2013 Income and patient-reported outcomes (PROs) after primary total knee arthroplastyBMC Medicine.  11. 2013
    2013 Racial and gender disparities among patients with goutCurrent Rheumatology Reports.  15. 2013
    2013 Are Gender, Comorbidity, and Obesity Risk Factors for Postoperative Periprosthetic Fractures After Primary Total Hip Arthroplasty?Journal of Arthroplasty.  28. 2013
    2013 Clinically important body weight gain following total hip arthroplasty: A cohort study with 5-year follow-upOsteoarthritis and Cartilage.  21:35-43. 2013
    2013 Medical comorbidity is associated with persistent index hip pain after total hip arthroplastyPain Medicine.  14:1222-1229. 2013
    2013 Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database.Arthritis Care and Research.  65:414-420. 2013
    2013 The State of US health, 1990-2010: Burden of diseases, injuries, and risk factors 2013
    2013 Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample sizePatient Preference and Adherence.  7:517-523. 2013
    2012 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010 2012
    2012 Emerging therapies for goutExpert Opinion on Emerging Drugs.  17:511-518. 2012
    2012 Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: A cohort study using an institutional joint registry 2012
    2012 Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesContemporary Clinical Trials.  33:1211-1216. 2012
    2012 Periprosthetic infections after total shoulder arthroplasty: A 33-year perspectiveJournal of Shoulder and Elbow Surgery.  21:1534-1541. 2012
    2012 Periprosthetic fractures associated with primary total shoulder arthroplasty and primary humeral head replacement: A thirty-three-year study 2012
    2012 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.Arthritis Care and Research.  64:1447-1461. 2012
    2012 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care and Research.  64:1431-1446. 2012
    2012 Periprosthetic infections after shoulder hemiarthroplastyJournal of Shoulder and Elbow Surgery.  21:1304-1309. 2012
    2012 ReplyArthritis Care and Research.  64:1623-1624. 2012
    2012 Total Knee Arthroplasty in Morbidly Obese Patients Treated With Bariatric Surgery. A Comparative StudyJournal of Arthroplasty.  27:1696-1700. 2012
    2012 Total knee arthroplasty volume, utilization, and outcomes among medicare beneficiaries, 1991-2010 2012
    2012 Patient Factors Predict Periprosthetic Fractures After Revision Total Hip ArthroplastyJournal of Arthroplasty.  27:1507-1512. 2012
    2012 Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacementActa Orthopaedica.  83:353-359. 2012
    2012 Risk factors for revision surgery after humeral head replacement: 1,431 shoulders over 3 decadesJournal of Shoulder and Elbow Surgery.  21:1039-1044. 2012
    2012 Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: Evidence from phase III randomized controlled trialsJournal of Rheumatology.  39:1450-1457. 2012
    2012 Stem cells and other innovative intra-articular therapies for osteoarthritis: What does the future hold?BMC Medicine.  10. 2012
    2012 Adverse effects of smoking on postoperative outcomes in cancer patientsAnnals of Surgical Oncology.  19:1430-1438. 2012
    2012 Cardiopulmonary Complications After Primary Shoulder Arthroplasty: A Cohort StudySeminars in Arthritis and Rheumatism.  41:689-697. 2012
    2012 Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trialBMC Medicine.  10. 2012
    2012 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care and Research.  64:625-639. 2012
    2012 A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative dataPharmacoepidemiology and Drug Safety.  21:265-273. 2012
    2012 Acetylcholinesterase inhibitors for schizophrenia.Cochrane Database of Systematic Reviews.  1. 2012
    2012 Developing a provisional definition of flare in patients with established goutArthritis and Rheumatism.  64:1508-1517. 2012
    2012 Ninety-day Mortality in Patients Undergoing Elective Total Hip or Total Knee ArthroplastyJournal of Arthroplasty.  27. 2012
    2012 Review: Biologic agents increase shortterm risk for some adverse events in conditions other than HIV or AIDSAnnals of Internal Medicine.  156. 2012
    2012 Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.Journal of Managed Care Pharmacy.  18. 2012
    2012 Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor 2012
    2012 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010 2012
    2011 Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplastyAnnals of the Rheumatic Diseases.  70:2082-2088. 2011
    2011 The attributable risk of smoking on surgical complicationsAnnals of Surgery.  254:914-920. 2011
    2011 Revision surgery following total shoulder arthroplasty: Analysis of 2588 shoulders over three decades (1976 to 2008) 2011
    2011 Comparison of patient-reported and clinician-assessed outcomes following total knee arthroplasty 2011
    2011 Ninety day mortality and its predictors after primary shoulder arthroplasty: An analysis of 4,019 patients from 1976-2008BMC Musculoskeletal Disorders.  12. 2011
    2011 Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplastyArthritis Care and Research.  63:1471-1476. 2011
    2011 Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veteransArthritis Care and Research.  63:1365-1374. 2011
    2011 Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis 2011
    2011 Smoking and outcomes after knee and hip arthroplasty: A systematic reviewJournal of Rheumatology.  38:1824-1834. 2011
    2011 Therapeutics: Biologicals for rheumatoid arthritisBMJ.  343. 2011
    2011 Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA Flare Definition Working GroupJournal of Rheumatology.  38:1745-1750. 2011
    2011 Hospital volume and surgical outcomes after elective hip/knee arthroplasty: A risk-adjusted analysis of a large regional databaseArthritis and Rheumatism.  63:2531-2539. 2011
    2011 Bringing it all together: A novel approach to the development of response criteria for chronic gout clinical trialsJournal of Rheumatology.  38:1467-1470. 2011
    2011 Early postoperative mortality following joint arthroplasty: A systematic reviewJournal of Rheumatology.  38:1507-1513. 2011
    2011 Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial (The Journal of Rheumatology (2010) 37, (2377-86))Journal of Rheumatology.  38:1534. 2011
    2011 Minimally important differences of the gout impact scale in a randomized controlled trialRheumatology.  50:1331-1336. 2011
    2011 Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized studyArthritis Care and Research.  63:1048-1054. 2011
    2011 Patient-reported outcomes in chronic gout: A report from OMERACT 10Journal of Rheumatology.  38:1452-1457. 2011
    2011 Serum urate in chronic gout - Will it be the first validated soluble biomarker in rheumatology?Journal of Rheumatology.  38:1462-1466. 2011
    2011 Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research prioritiesJournal of Rheumatology.  38:1458-1461. 2011
    2011 Validation of pain and patient global scales in chronic gout: Data from two randomised controlled trialsAnnals of the Rheumatic Diseases.  70:1277-1281. 2011
    2011 Health Care Utilization in Patients with GoutSeminars in Arthritis and Rheumatism.  40:501-511. 2011
    2011 Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care 2011
    2011 Responsiveness differences in outcome instruments after revision hip arthroplasty: What are the implications?BMC Musculoskeletal Disorders.  12. 2011
    2011 Surgery for shoulder osteoarthritis: A cochrane systematic reviewJournal of Rheumatology.  38:598-605. 2011
    2011 Biomarkers in arthroplasty: a systematic review.Open Orthopaedics Journal.  5:92-105. 2011
    2011 Diagnosis and management of infected total knee arthroplastyOpen Orthopaedics Journal.  5:86-91. 2011
    2011 Epidemiology of knee and hip arthroplasty: a systematic reviewOpen Orthopaedics Journal.  5:80-85. 2011
    2011 Botulinum toxin for shoulder pain: A cochrane systematic reviewJournal of Rheumatology.  38:409-418. 2011
    2011 Risk factors for gout and prevention: A systematic review of the literatureCurrent Opinion in Rheumatology.  23:192-202. 2011
    2011 Adverse effects of biologics: A network meta-analysis and Cochrane overviewCochrane Database of Systematic Reviews.  2011. 2011
    2011 The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: An international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacementOsteoarthritis and Cartilage.  19:147-154. 2011
    2011 Higher Body Mass Index Is Not Associated With Worse Pain Outcomes After Primary or Revision Total Knee ArthroplastyJournal of Arthroplasty.  26. 2011
    2011 Tocilizumab for rheumatoid arthritis: A cochrane systematic reviewJournal of Rheumatology.  38:10-20. 2011
    2010 Accuracy of VA databases for diagnoses of knee replacement and hip replacementOsteoarthritis and Cartilage.  18:1639-1642. 2010
    2010 Predictors of activity limitation and dependence on walking aids after primary total hip arthroplastyJournal of the American Geriatrics Society.  58:2387-2393. 2010
    2010 Predictors of doctor-rated and patient-rated gout severity: Gout impact scales improve assessmentJournal of Evaluation in Clinical Practice.  16:1244-1247. 2010
    2010 Applying science in practice: The optimization of biological therapy in rheumatoid arthritis 2010
    2010 Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trialJournal of Rheumatology.  37:2377-2386. 2010
    2010 Advances in gout: Some answers, more questions 2010
    2010 A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout managementArthritis Care and Research.  62:1306-1311. 2010
    2010 Gout in the Hmong in the United States 2010
    2010 Preferred roles in treatment decision making among patients with cancer: A pooled analysis of studies using the control preferences scaleAmerican Journal of Managed Care.  16:688-696. 2010
    2010 Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-yearsBMC Musculoskeletal Disorders.  11. 2010
    2010 Golimumab for rheumatoid arthritis: A systematic reviewJournal of Rheumatology.  37:1096-1104. 2010
    2010 Pessimistic explanatory style: A psychological risk factor for poor pain and functional outcomes two years after knee replacement 2010
    2010 Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study 2010
    2010 Predictors of moderate-severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-yearsOsteoarthritis and Cartilage.  18:515-521. 2010
    2010 Abatacept for rheumatoid arthritis: A cochrane systematic review (Journal of Rheumatology (2010) 37, (234-245) DOI:10.3899/jrheum.091066)Journal of Rheumatology.  37:682. 2010
    2010 Newer biological agents in rheumatoid arthritis: Impact on health-related quality of life and productivityDrugs.  70:121-145. 2010
    2010 Trial sample size, but not trial quality, is associated with positive study outcomeJournal of Clinical Epidemiology.  63:154-162. 2010
    2010 A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008Mayo Clinic Proceedings.  85:898-904. 2010
    2010 Abatacept for rheumatoid arthritis: A cochrane systematic reviewJournal of Rheumatology.  37:234-245. 2010
    2010 Biologics for rheumatoid arthritis: An overview of Cochrane reviews 2010
    2010 Botulinum toxin for shoulder pain.Cochrane Database of Systematic Reviews.  9. 2010
    2010 Botulinum toxin therapy for osteoarticular pain: An evidence-based reviewTherapeutic Advances in Musculoskeletal Disease.  2:105-118. 2010
    2010 Challenges with health-related quality of life assessment in arthroplasty patients: Problems and solutionsJournal of the American Academy of Orthopaedic Surgeons.  18:72-82. 2010
    2010 Golimumab for rheumatoid arthritis.Cochrane Database of Systematic Reviews2010
    2010 Pegloticase for chronic gout.Cochrane Database of Systematic Reviews.  3. 2010
    2010 Predictors of moderate-severe functional limitation 2 and 5 years after revision total knee arthroplastyJournal of Arthroplasty.  25. 2010
    2010 Surgery for shoulder osteoarthritis.Cochrane Database of Systematic Reviews2010
    2010 Tocilizumab for rheumatoid arthritis.Cochrane Database of Systematic Reviews.  7. 2010
    2009 Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplastyClinical Rheumatology.  28:1419-1430. 2009
    2009 Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplastyJournal of Rheumatology.  36:2642-2654. 2009
    2009 Biologics for rheumatoid arthritis: an overview of Cochrane reviews.Cochrane Database of Systematic Reviews2009
    2009 Surgery for shoulder osteoarthritisCochrane Database of Systematic Reviews2009
    2009 Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseasesAnnals of the Rheumatic Diseases.  68:1800-1804. 2009
    2009 A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: A Cochrane overviewCMAJ.  181:787-796. 2009
    2009 Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint painToxicon.  54:658-667. 2009
    2009 Acetylcholinesterase inhibitors for schizophreniaCochrane Database of Systematic Reviews2009
    2009 Discordance between self-report of physician diagnosis and administrative database diagnosis of arthritis and its predictorsJournal of Rheumatology.  36:2000-2008. 2009
    2009 Mobile and fixed-bearing (all-polyethylene tibial component) total knee arthroplasty designs: A prospective randomized trial 2009
    2009 Intrapericardial teratoma presenting as recurrent pericardial tamponade: Report of a caseSurgery Today.  39:700-704. 2009
    2009 Opportunities for improving medication use and monitoring in goutAnnals of the Rheumatic Diseases.  68:1265-1270. 2009
    2009 Anakinra for rheumatoid arthritis: A systematic reviewJournal of Rheumatology.  36:1118-1125. 2009
    2009 The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes 2009
    2009 Effect of resistance exercise on bone mineral density in premenopausal womenRevue du Rhumatisme.  76:439-447. 2009
    2009 Effect of resistance exercise on bone mineral density in premenopausal women 2009
    2009 Spondyloarthritis is associated with poor function and physical health-related quality of lifeJournal of Rheumatology.  36:1012-1020. 2009
    2009 Perceptions of disease and health-related quality of life among patients with goutRheumatology.  48:582-586. 2009
    2009 Toward a Valid Definition of Gout Flare: Results of Consensus Exercises Using Delphi Methodology and Cognitive MappingArthritis Care and Research.  61:535-543. 2009
    2009 Quality of life and quality of care for patients with goutCurrent Rheumatology Reports.  11:154-160. 2009
    2009 Health care utilization in patients with spondyloarthropathiesRheumatology.  48:272-276. 2009
    2009 Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases 2009
    2009 Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: Two casesRevue du Rhumatisme.  76:292-296. 2009
    2009 Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessmentRheumatology.  48:160-164. 2009
    2009 Abatacept for rheumatoid arthritis.Cochrane Database of Systematic Reviews2009
    2009 Accuracy of veterans affairs databases for diagnoses of chronic diseases 2009
    2009 Anakinra for rheumatoid arthritisCochrane Database of Systematic Reviews2009
    2009 Biologics for rheumatoid arthritis: An overview of Cochrane reviewsCochrane Database of Systematic Reviews2009
    2009 Editorial: Health care costs in gout: What are these emerging data telling us? 2009
    2009 Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty.Clinical Rheumatology.  28:1083-1089. 2009
    2009 Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty.Clinical Rheumatology.  28:1025-1033. 2009
    2009 Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial 2009
    2009 Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain 2009
    2008 Evaluation of an instrument assessing influence of gout on health-related quality of lifeJournal of Rheumatology.  35:2406-2414. 2008
    2008 Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplastyRheumatology.  47:1826-1831. 2008
    2008 Abatacept for rheumatoid arthritisCochrane Database of Systematic Reviews2008
    2008 Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veteransAnnals of the Rheumatic Diseases.  67:1310-1316. 2008
    2008 A rare cause of hypertension in children: Intrathoracic pheochromocytomaPediatric Surgery International.  24:865-867. 2008
    2008 A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic goutAnnals of the Rheumatic Diseases.  67:888-891. 2008
    2008 Anakinra for rheumatoid arthritisCochrane Database of Systematic Reviews2008
    2008 Chronic constrictive calcific pericarditisAsian Cardiovascular and Thoracic Annals.  16:432-433. 2008
    2008 Surgical management of aortic stenosis in a childMedical Journal Armed Forces India.  64:197-198. 2008
    2007 Assessment of outcome in clinical trials of gout - A review of current measuresRheumatology.  46:1751-1756. 2007
    2007 Improved health-related quality of life with effective disease-modifying antirheumatic drugs: Evidence from randomized controlled trialsAmerican Journal of Managed Care.  13. 2007
    2007 Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint painArthritis Care and Research.  57:1316-1323. 2007
    2007 Classification criteria in rheumatic diseases: A review of methodologie propertiesArthritis Care and Research.  57:1119-1133. 2007
    2007 The effects of intra-articular botulinum toxin on sacroiliac, cervical/lumbar facet and sternoclavicular joint pain and C-2 root and lumbar disc pain: A case series of 11 patientsPain Clinic.  19:27-32. 2007
    2007 Effect of health-related quality of life on women and men's veterans affairs (VA) health care utilization and mortalityJournal of General Internal Medicine.  22:1260-1267. 2007
    2007 Quality of care for gout in the US needs improvementArthritis Care and Research.  57:822-829. 2007
    2007 Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databasesArthritis Care and Research.  57:648-655. 2007
    2007 Contributions of OMERACT to rheumatic disease research [1]Arthritis Care and Research.  57:186. 2007
    2006 Long term effects of intra-articular botulinum toxin a for refractory joint painNeurotoxicity Research.  9:179-188. 2006
    2006 Spondyloarthropathy: An independent risk factor for kidney stones 2006
    2006 Antibiotics for reactive arthritisCochrane Database of Systematic Reviews.  2006. 2006
    2006 Management of Superior Vena Cava Syndrome by Internal Jugular to Femoral Vein BypassAnnals of Thoracic Surgery.  82:310-312. 2006
    2006 Development of classification and response criteria for rheumatic diseasesArthritis Care and Research.  55:348-352. 2006
    2006 Use of breath carbon monoxide measurements to assess erythrocyte survival in subjets with chronic diseasesAmerican Journal of Hematology.  81:432-438. 2006
    2006 Left ventricule rupture after mitral valve replacement [1]Asian Cardiovascular and Thoracic Annals.  14:537. 2006
    2005 Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: A preliminary reportLupus.  14:137-144. 2005
    2005 Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life studySeminars in Arthritis and Rheumatism.  34:755-765. 2005
    2005 Health-related quality of life, functional impairment, and healthcare utilization by veterans: Veterans' quality of life studyJournal of the American Geriatrics Society.  53:108-113. 2005
    2005 Opioid use by patients in an orthopedics spine clinicArthritis and Rheumatism.  52:312-321. 2005
    2004 Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritisArthritis Care and Research.  51:952-957. 2004
    2004 Immunohistochemistry of normal synovium [2] (multiple letters)Annals of the Rheumatic Diseases.  63:1532-1533. 2004
    2004 Immunohistochemistry of normal human knee synovium: A quantitative studyAnnals of the Rheumatic Diseases.  63:785-790. 2004
    2004 Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid- naïve patientsJournal of Rheumatology.  31:1281-1285. 2004
    2003 Leflunomide Use during the First 33 Months after Food and Drug Administration Approval: Experience with a National Cohort of 3,325 PatientsArthritis Care and Research.  49:745-751. 2003
    2003 Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: A new syndrome? 2003
    2003 Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: a new syndrome? 2003
    2002 Ciprofloxacin-related acute peripheral neuropathy in a patient with lupus nephritis 2002
    Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study

    Chapter

    Year Title Altmetric
    2016 PROMs for gouty arthritis.  225-247. 2016
    2014 Botulinum toxin applications in musculoskeletal pain & arthritis 2014
    2013 Treatment Guidelines in Rheumatoid Arthritis 2013
    2012 Quality of care in gout.  209-216. 2012
    2011 Gouty Arthritis.  86-92. 2011
    2009 Botulinum Toxin for Osteoarticular Pain.  295-307. 2009
    2009 Health-Related Quality of Life in Rheumatoid Arthritis.  237-259. 2009
    2007 Gout 2007

    Research Overview

  • Dr. Singh’s research interests include studies of patient-reported outcomes, health disparities and comparative effectiveness research (CER) in rheumatic diseases including gout, osteoarthritis, lupus, rheumatoid arthritis, and total joint replacement. He has led the performance of Cochrane systematic reviews, network meta-analyses and the ACR treatment guidelines. His team has also lead mixed methods research with patients with rheumatic diseases assessing patient attitudes, beliefs and priorities in various rheumatic diseases.
  • Principal Investigator On

  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT) - Project 4: Protecting Renal Function with Urate-Lowering Drugs  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • Implementation of DEcision-Aid for Lupus in Practice Settings for Shared Decision-Making (SOM): IDEAL Study  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2018 - 2021
  • Improving Minority Health in Rheumatic Diseases  awarded by Medical University of South Carolina 2019 - 2021
  • Private Grant  awarded by BIOMET BIOLOGICS, LLC 2016 - 2019
  • Quantifying Underuse and Overuse of Knee Replacement  awarded by Northwestern University 2016 - 2018
  • Individualized Patient Decision Making for Treatment Choices Among Minorities with Lupus  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2013 - 2018
  • Centers of Research Translation (CoRT) - Project 3  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Quantifying Underuse and Overuse of Knee Replacement  awarded by Weill (Joan and Sanford I.) Medical College of Cornell University 2016
  • ACOSOG Communtiy Clinical Oncology Program (CCOP) Research Base  awarded by MAYO CLINIC 2011 - 2016
  • Detection and Analysis of Adverse Events related to Regulated Products in Automated Healthcare Data: Efforts to Develop the Sentinel Initiative  awarded by HARVARD PILGRIM HEALTH CARE 2010 - 2011
  • Update of ACR 2008 Biologic and Non-Biologic DMARD Recommendations for RA  awarded by American College of Rheumatology 2010 - 2011
  • Investigator On

  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT) - Administrative Core  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by SWEDISH ORPHAN BIOVITRUM AB 2017 - 2022
  • Private Grant  awarded by AMPEL BIOSOLUTIONS 2016 - 2021
  • Private Grant  awarded by GlaxoSmithKline 2018 - 2021
  • Multicenter Osteoarthritis Study (MOST) Second Renewal - UAB Clinical Center  awarded by National Institute on Aging/NIH/DHHS 2015 - 2021
  • Overcoming TWEAK Signaling to Restore Muscle and Mobility after Joint Replacement  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2015 - 2020
  • Centers of Research Translation (CoRT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Centers of Research Translation (CoRT) - Administrative Core  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • UAB Deep South Arthritis and Musculoskeletal CERTs  awarded by Agency for Healthcare Research and Quality/DHHS 2011 - 2017
  • Effectiveness of DiscontinuinG BisphosphonatEs Study (EDGE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2016
  • Multicenter Osteoarthritis Study (MOST) Renewal  awarded by National Institute on Aging/NIH/DHHS 2008 - 2015
  • Deep South Musculoskeletal Certs (DSMC)  awarded by Agency for Healthcare Research and Quality/DHHS 2007 - 2012
  • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), 1993
  • Master of Public Health in Epidemiology, University of Minnesota System : Twin Cities 1993
  • SUNY Upstate Hospital, Internship 1996
  • SUNY Upstate Hospital, Residency 1998
  • Barnes-Jewish West County Hospital, Postdoctoral Fellowship 2001
  • Full Name

  • Jasvinder Singh